<DOC>
	<DOCNO>NCT00408473</DOCNO>
	<brief_summary>The purpose study assess efficacy flecainide control release ( CR ) prevention recurrent AF 9 month active treatment compare placebo patient one document AF episode .</brief_summary>
	<brief_title>Comparative Study Flecainide CR Placebo Early Treatment Atrial Fibrillation .</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Flecainide</mesh_term>
	<criteria>History first symptomatic &amp; documented episode AF LVEF &gt; 40 % AAD sinus rhythm time recruitment History 1 symptomatic document AF episode , persistent permanent AF . History ablation previous AF Reversible cause AF ( e.g.thyroid , alcohol , pulmonary embolism , surgery Severe symptom AF episode ( e.g.syncope , chest pain ) All type treat arrhythmias AF History myocardial infarction ( MI ) , coronary artery disease ( CAD ) , heart failure ( I , II , III IV New York Heart Association NYHA classification ) valvular disease Left ventricular ejection fraction ( LVEF ) ≤ 40 % Bradycardia &lt; 40 beats/min ECG abnormality : PR &gt; 240ms QRS &gt; 120 m QTc &gt; 440 m Brugada syndrome Conduction disturbance : complete bundle branch block ( LBBB ) ( RBBB ) , bifascicular block 2nd 3rd degree atrioventricular ( AV ) block Sinus node dysfunction Severe hypertension : Systolic blood pressure ≥ 180 mmHg , / or· Diastolic blood pressure ≥ 100 mmHg Left ventricular hypertrophy ( LVH ) septal thickness &gt; 14 mm Echocardiogram Implanted pacemaker Heart surgery within last 6 month , nonstable postoperative condition Renal failure : serum creatinine ≥ 150 µmol/l creatinine clearance ≤ 50 ml/min ( Cockroft Gault formula Uncorrected electrolytic abnormality Have use recently last 3 month prior inclusion follow treatment : Oral amiodarone , Treatments lengthen QT interval ( e.g.Sultopride , Drugs cause torsades de pointe ( e.g.mizolastine , pentamidine , sparfloxacin , moxifloxacin , Bupropion Antihypertensive drug permit study : ACEI , ARB ( sartans ) DHP Calcium channel blocker ( CCB</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2007</verification_date>
</DOC>